Literature DB >> 19414742

Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.

Caroline T Tiemessen1, Sharon Shalekoff, Stephen Meddows-Taylor, Diana B Schramm, Maria A Papathanasopoulos, Glenda E Gray, Gayle G Sherman, Ashraf H Coovadia, Louise Kuhn.   

Abstract

Most infants exposed to HIV-1 in utero and at delivery do not acquire infection. We show that mothers and infants who have CD3-negative cells that respond to HIV-1 peptides are substantially less likely to transmit and acquire infection, respectively. The CD3-negative cells, shown to be NK cells, respond with remarkable specificity and high magnitude to HIV-1 peptides from Env (envelope) and Reg (regulatory) protein regions, as measured by a whole blood intracellular cytokine assay only in the context of HIV-1 infection or exposure. These findings identify an important new measure of protective immunity to HIV-1 that highlights the importance of innate immunity in preventing the establishment of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414742      PMCID: PMC2841685          DOI: 10.4049/jimmunol.0900419

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  NK cell recognition.

Authors:  Lewis L Lanier
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

3.  T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus.

Authors:  Xiao-Song He; Monia Draghi; Kutubuddin Mahmood; Tyson H Holmes; George W Kemble; Cornelia L Dekker; Ann M Arvin; Peter Parham; Harry B Greenberg
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

4.  Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection.

Authors:  M I de Moraes-Pinto; A C Almeida; G Kenj; T E Filgueiras; W Tobias; A M Santos; M M Carneiro-Sampaio; C K Farhat; P J Milligan; P M Johnson; C A Hart
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

5.  Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.

Authors:  S Gaudieri; D DeSantis; E McKinnon; C Moore; D Nolan; C S Witt; S A Mallal; F T Christiansen
Journal:  Genes Immun       Date:  2005-12       Impact factor: 2.676

Review 6.  NK cells in HIV infection: paradigm for protection or targets for ambush.

Authors:  Anthony S Fauci; Domenico Mavilio; Shyam Kottilil
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

7.  Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers.

Authors:  Sharon Shalekoff; Stephen Meddows-Taylor; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn; Caroline T Tiemessen
Journal:  AIDS       Date:  2009-04-27       Impact factor: 4.177

8.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

9.  Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users.

Authors:  Daniel Scott-Algara; Lien X Truong; Pierre Versmisse; Annie David; Tram T Luong; Ngai V Nguyen; Ioannis Theodorou; Françoise Barré-Sinoussi; Gianfranco Pancino
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 10.  Human natural killer cell receptors and co-receptors.

Authors:  R Biassoni; C Cantoni; D Pende; S Sivori; S Parolini; M Vitale; C Bottino; A Moretta
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

View more
  36 in total

1.  A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.

Authors:  Diego A Vargas-Inchaustegui; Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.

Authors:  Costin Tomescu; Fuh-Mei Duh; Michael A Lanier; Angela Kapalko; Karam C Mounzer; Maureen P Martin; Mary Carrington; David S Metzger; Luis J Montaner
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

3.  Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Authors:  Caroline T Tiemessen; Sharon Shalekoff; Stephen Meddows-Taylor; Diana B Schramm; Maria A Papathanasopoulos; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

4.  In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth.

Authors:  B Lohman-Payne; T Sandifer; M OhAinle; C Crudder; J Lynch; M M Omenda; J Maroa; K Fowke; G C John-Stewart; C Farquhar
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 5.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

6.  Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection.

Authors:  Melanie A Gasper; Pratima Kunwar; Grace Itaya; Nicholas Lejarcegui; Rose Bosire; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Jennifer Slyker; Julie Overbaugh; Helen Horton; Donald L Sodora; Grace John-Stewart; Barbara Lohman-Payne
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

7.  Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.

Authors:  Zelda Euler; Galit Alter
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

8.  High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.

Authors:  Justin Pollara; Lydia Hart; Faraha Brewer; Joy Pickeral; Beverly Z Packard; James A Hoxie; Akira Komoriya; Christina Ochsenbauer; John C Kappes; Mario Roederer; Ying Huang; Kent J Weinhold; Georgia D Tomaras; Barton F Haynes; David C Montefiori; Guido Ferrari
Journal:  Cytometry A       Date:  2011-07-06       Impact factor: 4.355

9.  Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.

Authors:  Vijaya Madhavi; Marjon Navis; Amy W Chung; Gamze Isitman; Leia H Wren; Robert De Rose; Stephen J Kent; Ivan Stratov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

10.  Enhanced and efficient detection of virus-driven cytokine expression by human NK and T cells.

Authors:  Laura Pattacini; Pamela M Murnane; Tayler R Fluharty; Elly Katabira; Stephen C De Rosa; Jared M Baeten; Jennifer M Lund
Journal:  J Virol Methods       Date:  2014-01-10       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.